Robert D. Mitchell

Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA.

Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN.

Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark

Cook Medical LLC is a family-owned medical device company that works with physicians to develop devices that are less invasive for patients. It offers Endovascular treatment solutions for abdominal and thoracic aortic disease; products for managing difficult airway, centesis and drainage, enteral feeding, vascular access, and tracheostomy; accessories for endoscopic procedures to both diagnose and treat diseases throughout the gastrointestinal tract; image-guided diagnostic and therapeutic devices for percutaneous drainage, centesis, venous access, biopsy, liver access, embolization, and enteral feeding procedures; devices and related accessories for percutaneous cardiac lead extraction procedures and specialized introducer sheath products; products to help treat obstructive salivary gland disorders, chronic rhinosinusitis and dysphagia as well as head and neck advanced tissue repair grafts and biopsy needles; products for the treatment of vascular conditions, including peripheral arterial and venous diseases; products to support patient pathways; products for general surgery, microvascular and plastic surgery, minimally invasive surgery, upper-GI surgery, and colorectal surgery; and products that support diagnostic and therapeutic procedures in adult and pediatric urology, with an emphasis on stone management, and male and female pelvic health. The company was founded by William Alfred Cook in 1963 and is headquartered in Bloomington, IN.

Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA.